2023 PT and APTT Point-of-Care Testing Market: 2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

July 2023 | | ID: 2B0975528DF9EN
Venture Planning Group

Abstracts

This new report from VPGMarketResearch provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

• Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
• Five-year test volume and reagent sales forecasts for clinical chemistry procedures by market segment:
• Physician Offices/Group Practices
• Emergency Rooms
• Operating/Recovery Suites
• ICUs/CCUs
• Ambulatory Care Centers
• Surgery Centers
• Nursing Homes
• Birth Centers

Sales and Market Share Analysis

• Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

• Analysis of coagulation procedures performed in POC testing locations.
• Review of leading coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

• Emerging technologies and their applications for POC testing.
• Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.

Competitive Assessments

• Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

• Specific opportunities for new coagulation instruments and reagent systems with potentially significant market appeal during the next five years.
• Design criteria for POC testing products.
• Alternative business expansion strategies.
• Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contents

INTRODUCTION

Executive Summary
Rationale for Testing Decentralization
  1. Overview
  2. Regulatory Trends
  3. Economic Trends
  4. Demographic Trends
  5. Technological Trends
  6. Social Trends
  7. Quality of Care
  8. Defensive Medicine
  9. Quality Control Issues

WORLDWIDE @MARKET AND TECHNOLOGY OVERVIEW

  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Prothrombin Time (PT)
Instrumentation: Coagulation Analyzers Manufactured by:
Behnk Elektronik
Bio/Data
Cardiovascular Diagnostics
Diagnostica Stago
Helena Laboratories
Instrumentation Laboratory
ITC Hemochron
Roche
Siemens
Sysmex
Teco Medical Instruments
Trinity Biotech
Current and Emerging Technologies
  1. Monoclonal Antibodies
  2. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
    c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
    d. Luminescence
Chemiluminescence
Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  3. Dry Chemistry
  4. Biosensors
  5. IT and Automation
  6. Molecular Diagnostics
    a. Technology Overview
    b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
  1. Business Environment
    a. Health Care Expenditures
    b. Cost Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
PPO
HMO
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
    l. Laboratory Regulations
  2. Market Structure
    a. Hospitals
    b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
  1. Market Summary
  2. Market Structure
  3. Test Volume and Sales Forecasts
C. Ancillary Hospital Locations
  1. Introduction
    a. Emergency Departments
    b. Operating Suites
    c. Intensive Care Units
  2. Emergency Departments
    a. Market Summary
    b. Test volume and Sales Forecasts
  3. Operating and Recovery Suites
    a. Market Summary
    b. Test Volume and Sales Forecasts
  4. ICUs/CCUs
    a. Market Summary
    b. Test Volume and Sales Forecasts
D. Cancer Clinics
  1. Introduction
  2. Market Summary
  3. Test Volume and Sales Forecasts
E. Ambulatory Care Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
F. Surgery Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
G. Nursing Homes
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
H. Birth Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts

I. MAJOR SUPPLIERS’ INSTRUMENT PLACEMENTS, INSTALLED BASE, CONSUMABLES SALES AND MARKET SHARES

Germany
A. Market Overview
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
Spain
A. Business Environment
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
Major Product Development Opportunities
A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
Abbott
Accriva
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPHEN BioMed
Instrumentation Laboratory/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sienco
Sysmex
Thermo Fisher

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing PT Tests
U.S.A., Physician Office/Group Practice
Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
PT and APTT Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments
PT and APTT Test Volume Forecast
U.S.A., Hospital Emergency Departments
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Hospital Operating and Recovery Suites
PT and APTT Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Hospital ICUs/CCUs
PT and APTT Test Volume Forecast
U.S.A., Hospital ICUs/CCUs
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Cancer Clinics Major
PT and APTT Test Volume Forecast
U.S.A., Cancer Clinics
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers
Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers
PT and APTT Test Volume Forecast
U.S.A., Ambulatory Care Centers
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Surgery Centers Most
Frequently Performed Procedures
U.S.A., Surgery Centers
PT and APTT Test Volume Forecast
U.S.A., Surgery Centers
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Nursing Homes
Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes
PT and APTT Test Volume Forecast
U.S.A., Nursing Homes
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers
PT and APTT Test Volume Forecast
U.S.A., Birth Centers
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Major Suppliers of Coagulation
Diagnostic Products Estimated Market Shares
Germany, Laboratory Performing Diagnostic Tests by Market Segment
Germany, Physician Offices/Group Practices
PT and APTT Test Volume Forecast
Germany, Physician Offices/Group Practices
Coagulation Reagent and Instrument Sales Forecast
Germany, Major Suppliers of Coagulation
Diagnostic Products Estimated Market Shares
Spain, Laboratory Performing PT and APTT
Tests by Market Segment
Spain, Ambulatory Care Centers
PT and APTT Test Volume Forecast
Spain, Ambulatory Care Centers
Coagulation Reagent and Instrument Sales Forecast
Spain, Major Suppliers of Coagulation
Diagnostic Products Estimated Market Shares